Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 20-Jun-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
19-Jun-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
18-Jun-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Elite Pharmaceuticals, Inc. 40 $460 View Abstract
14-Jun-13 Reuters Investment Profile N/A Elite Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (Global) 105 $1207.50 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) 78 $897 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) 77 $885.50 View Abstract
14-Jun-13 Ford Investor Services, Inc. N/A Industry Value Graph: APRI , CORT , ELTP , GALT , MNOV , RGRX -- DRUGS 3 $34.50 View Abstract
14-Jun-13 Ford Investor Services, Inc. N/A Value Graph: ELITE PHARMACEUT -- ELTP 1 $11.50 View Abstract
23-May-13 Plunkett Research, Ltd. Jack W Plunkett Elite Pharmaceuticals, Inc. (ELTP) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages 49 $99 View Abstract
21-May-13 GlobalData GlobalData Elite Pharmaceuticals, Inc. (ELTP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile 28 $250 View Abstract

Independent Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price More Info
19-Jun-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
18-Jun-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Elite Pharmaceuticals, Inc. 40 $460 View Abstract
14-Jun-13 Reuters Investment Profile N/A Elite Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (Global) 105 $1207.50 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) 78 $897 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) 77 $885.50 View Abstract
14-Jun-13 Ford Investor Services, Inc. N/A Industry Value Graph: APRI , CORT , ELTP , GALT , MNOV , RGRX -- DRUGS 3 $34.50 View Abstract
14-Jun-13 Ford Investor Services, Inc. N/A Value Graph: ELITE PHARMACEUT -- ELTP 1 $11.50 View Abstract
23-May-13 Plunkett Research, Ltd. Jack W Plunkett Elite Pharmaceuticals, Inc. (ELTP) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages 49 $99 View Abstract
21-May-13 GlobalData GlobalData Elite Pharmaceuticals, Inc. (ELTP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile 28 $250 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.